Akcie v oběhu společnosti Starpharma
Jaká je hodnota metriky Akcie v oběhu společnosti Starpharma?
Hodnota metriky Akcie v oběhu společnosti Starpharma Holdings Limited je 381.437M 93.79%
Jaká je definice metriky Akcie v oběhu?
Akce v oběhu (Shares float) je podíl akcií společnosti vlastněných veřejnými investory vůči zablokovaným akcím (nejsou volně v oběhu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v oběhu společností v sektoru Health Care sektor na ASX ve srovnání se společností Starpharma
Čemu se věnuje společnost Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Firmy s metrikou akcie v oběhu podobnou společnosti Starpharma
- Hodnota metriky Akcie v oběhu společnosti Paragon Care je 380.382M 108.25%
- Hodnota metriky Akcie v oběhu společnosti BikeExchange Pty Ltd je 380.754M 129.95%
- Hodnota metriky Akcie v oběhu společnosti Edison International je 380.967M 100.28%
- Hodnota metriky Akcie v oběhu společnosti Under Armour je 381.018M 84.98%
- Hodnota metriky Akcie v oběhu společnosti Under Armour je 381.018M 201.93%
- Hodnota metriky Akcie v oběhu společnosti Edison International je 381.409M 117.06%
- Hodnota metriky Akcie v oběhu společnosti Starpharma je 381.437M 93.79%
- Hodnota metriky Akcie v oběhu společnosti Zioncom je 381.579M 57.82%
- Hodnota metriky Akcie v oběhu společnosti QYOU Media je 381.671M 95.23%
- Hodnota metriky Akcie v oběhu společnosti Luxey International () je 381.755M 48.34%
- Hodnota metriky Akcie v oběhu společnosti Goal Forward je 381.961M 25.26%
- Hodnota metriky Akcie v oběhu společnosti Covestro AG je 382.061M 98.90%
- Hodnota metriky Akcie v oběhu společnosti Aura je 382.242M 90.85%